HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.

AbstractAIM:
Improved treatments for prostate cancer are critically needed in order to overcome metastasis and lethal recurrence. Intravenously administered gene therapy would be an attractive anticancer treatment strategy; however, the lack of suitable carrier systems able to selectively deliver therapeutic genes to tumors has so far limited this investigation. Given that transferrin receptors are overexpressed on prostate cancer cells, the purpose of this study is to determine whether transferrin-conjugated dendriplexes encoding TNF-α, TNF-related apoptosis-inducing ligand and IL-12 would suppress the growth of prostate cancer cell lines in vitro and in vivo.
MATERIALS & METHODS:
Transferrin-conjugated dendriplexes encoding TNF-α, TNF-related apoptosis-inducing ligand and IL-12 were intravenously administered to mice bearing subcutaneous PC-3 and DU145 tumors.
RESULTS:
The administration of the transferrin-conjugated generation 3 diaminobutyric polypropylenimine dendriplex encoding TNF-a resulted in tumor suppression for 60% of PC-3 and 50% of DU145 prostate tumors.
CONCLUSION:
These dendriplexes hold great potential as a novel approach for prostate cancer therapy.
AuthorsMajed Al Robaian, Ker Yi Chiam, David R Blatchford, Christine Dufès
JournalNanomedicine (London, England) (Nanomedicine (Lond)) Vol. 9 Issue 4 Pg. 421-34 (Apr 2014) ISSN: 1748-6963 [Electronic] England
PMID24910874 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dendrimers
  • Polypropylenes
  • TNF-Related Apoptosis-Inducing Ligand
  • Transferrin
  • Tumor Necrosis Factor-alpha
  • poly(propyleneimine)
  • Interleukin-12
  • DNA
Topics
  • Administration, Intravenous
  • Animals
  • Cell Line, Tumor
  • DNA (administration & dosage, genetics, therapeutic use)
  • Dendrimers (chemistry)
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Humans
  • Interleukin-12 (genetics)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Plasmids (administration & dosage, genetics, therapeutic use)
  • Polypropylenes (chemistry)
  • Prostate (drug effects, metabolism, pathology)
  • Prostatic Neoplasms (genetics, pathology, therapy)
  • TNF-Related Apoptosis-Inducing Ligand (genetics)
  • Transferrin (chemistry)
  • Tumor Necrosis Factor-alpha (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: